Protara Therapeutics (TARA)
NASDAQ:TARA
Holding TARA?
Track your performance easily

Protara Therapeutics (TARA) Financial Statements

562 Followers

Protara Therapeutics Financial Overview

Protara Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.187; its P/E ratio is -0.62; Protara Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 4.00K
Gross Profit----$ 4.00K
EBIT$ -9.51M$ 12.61M$ -11.04M$ -9.86M$ -11.29M
EBITDA$ -9.19M$ 12.87M$ -10.93M$ -9.88M$ -11.01M
Net Income Common Stockholders$ -9.51M$ -11.10M$ -10.22M$ -9.86M$ -11.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.58M$ 55.22M$ 65.58M$ 74.03M$ 80.36M
Total Assets$ 101.65M$ 68.13M$ 78.95M$ 88.47M$ 95.14M
Total Debt$ 4.98M$ 5.23M$ 5.47M$ 5.70M$ 5.93M
Net Debt$ -84.60M$ -50.00M$ -60.11M$ -68.33M$ -74.43M
Total Liabilities$ 9.60M$ 9.73M$ 10.63M$ 11.51M$ 9.92M
Stockholders Equity$ 92.05M$ 58.41M$ 68.32M$ 76.96M$ 85.22M
Cash Flow-
Free Cash Flow$ -7.74M$ -10.38M$ -8.70M$ -6.60M$ -9.41M
Operating Cash Flow$ -7.69M$ -10.38M$ -8.70M$ -6.56M$ -9.41M
Investing Cash Flow$ 2.94M$ 23.10M$ 14.52M$ 6.38M$ 22.35M
Financing Cash Flow$ 42.09M$ -76.00K-$ -27.00K-
Currency in USD

Protara Therapeutics Earnings and Revenue History

Protara Therapeutics Debt to Assets

Protara Therapeutics Cash Flow

Protara Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis